ABT

Abbott Laboratories

Healthcare
86.96 -0.78 -0.89% Market Closed
2026-06-02 • USD

Key Metrics

Market Cap 151.47B
EV —
Shares Out 1.74B
Revenue (ttm) 45.13B
Net Income 6.28B
Beta —
P/E 24.14
Forward P/E —
EPS (ttm) $3.57
P/S 3.36
P/B 2.91
P/FCF —
P/C —
EV/Sales —
EV/EBITDA —
ROA 6.46%
ROE 12.23%
ROIC 6.9%
Gross Margin —
Oper. Margin 17.07%
Profit Margin 13.91%
Debt/Eq 0.65
LT Debt/Eq 36.28%
Quick Ratio —
Current Ratio 1.39
Book/sh 29.88
Cash/sh 3.9
Div Yield 2.81%
Div TTM $2.44
Payout Ratio 68.35%
SMA20 0.87%
SMA50 -6.94%
SMA200 -25.14%
Volume 7,126,327
Avg Volume 12.19M
Rel Volume —
Perf Week 1.59%
Perf Month -0.24%
Perf Quarter -21.69%
Perf Half Y -30.48%
Perf YTD -30.59%
Perf Year -35.08%
Perf 3Y -16.19%
Perf 5Y -20.43%

Factor Lens

Seasonal Performance

Dividends

Per-share amounts adjusted for stock splits.

Last Dividend $0.6300
TTM Yield 2.81%
TTM Amount $2.44
Payout Ratio 68.35%
3-Yr Growth (CAGR) 7.72%
5-Yr Growth (CAGR) 46.14%

Last 12 Payouts

Period Ex-Date Amount / Share
Q1 2026 ~2026-03-31 $0.6300
Q4 2025 ~2025-12-30 $0.6300
Q3 2025 ~2025-09-30 $0.5900
Q2 2025 ~2025-06-30 $0.5900
Q1 2025 ~2025-03-31 $0.5900
Q4 2024 ~2024-12-30 $0.5900
Q3 2024 ~2024-09-30 $0.5500
Q2 2024 ~2024-06-30 $0.5500
Q1 2024 ~2024-03-31 $0.5500
Q3 2023 ~2023-09-30 $0.5100
Q1 2020 ~2020-03-31 $0.3600
Q1 2019 ~2019-03-31 $0.3200

Financial Trends

Revenue & Net Income

Earnings Per Share

Margins

Cash Flow

Company Overview

Abbott Laboratories is a diversified global healthcare company that develops, manufactures, and distributes a broad range of pharmaceuticals, diagnostic products, nutritional products, and medical devices. The company operates through four main segments: Established Pharmaceutical Products (including key emerging market medicines), Nutritional Products (pediatric and adult nutritionals), Diagnostic Products (including core laboratory, molecular, point-of-care, and rapid diagnostics), and Medical Devices (including rhythm management, electrophysiology, heart failure, vascular, structural heart, neuromodulation, and diabetes care solutions). Abbott's products and services reach approximately 2 billion people globally, with operations in more than 160 countries. The company focuses on innovation for access and affordability, transforming care for chronic diseases and infectious diseases, and advancing health access through partnerships with stakeholders to improve health outcomes.

Name
Abbott Laboratories
Industry
Drug Manufacturers - General
CEO
Robert B. Ford · Chairman of the Board and Chief Executive Officer
Employees
—
IPO Date
2018-05-01
Phone
2246676100
Address
100 Abbott Park Road, Abbott Park, IL 60064-6400
Website
http://www.abbott.com

Key Executives

Name Title FY Pay
Carla Kriwet Executive Vice President, Chief Sustainability Officer —
Anil Sood Executive Vice President, Chief Medical Officer —
Daniel J. Surdell Executive Vice President, General Counsel and Corporate Secretary —
Jaime Contreras Executive Vice President, Chief Financial Officer —
Robert B. Ford Chairman of the Board and Chief Executive Officer —

Latest News